Integra Lifesciences Holdings (IART) Raw Materials (2010 - 2017)

Integra Lifesciences Holdings (IART) posted Raw Materials of $48.4 million for Q3 2017, up 23.2% sequentially from $39.2 million in Q4 2016.

Integra Lifesciences Holdings (IART) Raw Materials (2010 - 2017) Analysis & Trends

Integra Lifesciences Holdings has reported Raw Materials for 7 years, with the latest figure at $48.4 million in Q3 2017.

Quarterly Raw Materials changed N/A year-over-year to $48.4 million in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $48.4 million (changed N/A YoY) and the FY2016 annual result came in at $39.2 million, changed N/A from the prior year.
Raw Materials climbed to $48.4 million in Q3 2017 per IART's latest filing, from $39.2 million in the prior quarter.
Over five years, Raw Materials peaked at $48.4 million in Q3 2017 and troughed at $36.5 million in Q4 2014.
A 4-year average of $41.1 million and a median of $39.7 million in 2015 frame the typical range for Raw Materials.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Integra Lifesciences Holdings	1.28 Bn	1.01 Bn	219.74 Mn

Download Data